Total Payments
$8,339
2024 Payments
$2,380
Companies
44
Transactions
513
Medicare Patients
1,710
Medicare Billing
$139,185
Payment Breakdown by Category
Food & Beverage$8,237 (98.8%)
Education$101.50 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,237 | 512 | 98.8% |
| Education | $101.50 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $881.17 | 66 | $0 (2024) |
| ABBVIE INC. | $845.59 | 59 | $0 (2024) |
| Celgene Corporation | $578.98 | 64 | $0 (2024) |
| PFIZER INC. | $531.65 | 34 | $0 (2024) |
| SK Life Science, Inc. | $495.26 | 16 | $0 (2024) |
| UCB, Inc. | $484.73 | 27 | $0 (2024) |
| ARGENX US, INC. | $329.76 | 15 | $0 (2024) |
| Neurelis, Inc. | $295.32 | 14 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $287.11 | 26 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $277.17 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,380 | 132 | PFIZER INC. ($303.86) |
| 2023 | $2,610 | 160 | AbbVie Inc. ($377.13) |
| 2022 | $1,718 | 121 | Biohaven Pharmaceutical Holding Company Ltd. ($268.63) |
| 2021 | $313.96 | 19 | Teva Pharmaceuticals USA, Inc. ($121.24) |
| 2020 | $339.02 | 18 | Teva Pharmaceuticals USA, Inc. ($116.76) |
| 2019 | $314.09 | 17 | Teva Pharmaceuticals USA, Inc. ($79.20) |
| 2018 | $328.20 | 24 | Supernus Pharmaceuticals, Inc. ($131.76) |
| 2017 | $334.97 | 22 | Supernus Pharmaceuticals, Inc. ($143.34) |
All Payment Transactions
513 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Neurology | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: PAIN | ||||||
| 12/06/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Neurology | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $27.06 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.34 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Central Nervous System | ||||||
| 11/04/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $35.03 | General |
| 10/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $20.85 | General |
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: PAIN | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: EPILEPSY | ||||||
| 10/15/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Central Nervous System | ||||||
| 10/12/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Neurology | ||||||
| 10/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Neurology | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $33.07 | General |
| Category: Neurology | ||||||
| 10/03/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/02/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: EPILEPSY | ||||||
| 09/26/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 347 | 386 | $86,813 | $27,953 |
| 2022 | 12 | 413 | 457 | $107,081 | $34,640 |
| 2021 | 15 | 481 | 536 | $119,534 | $39,436 |
| 2020 | 14 | 469 | 503 | $108,186 | $37,156 |
Total Patients
1,710
Total Services
1,882
Medicare Billing
$139,185
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 50 | 50 | $15,500 | $6,436 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 52 | 58 | $9,280 | $3,735 | 40.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 30 | 33 | $6,996 | $3,479 | 49.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 39 | 39 | $9,750 | $3,059 | 31.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 63 | 90 | $15,030 | $2,836 | 18.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 17 | 17 | $7,939 | $2,655 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 39 | 41 | $4,510 | $1,862 | 41.3% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 26 | 26 | $9,724 | $1,785 | 18.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 13 | $3,068 | $1,211 | 39.5% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 19 | 19 | $5,016 | $893.34 | 17.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 41 | 41 | $12,710 | $5,521 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 60 | 66 | $10,560 | $4,467 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 55 | 55 | $13,750 | $4,197 | 30.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 27 | $12,609 | $3,593 | 28.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 66 | 96 | $16,032 | $3,256 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 62 | 69 | $7,590 | $3,152 | 41.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $4,844 | $2,170 | 44.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 21 | 21 | $4,452 | $1,884 | 42.3% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Facility | 2022 | 12 | 12 | $4,200 | $1,853 | 44.1% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 17 | 18 | $7,992 | $1,796 | 22.5% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 21 | 21 | $7,854 | $1,682 | 21.4% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 17 | 17 | $4,488 | $1,070 | 23.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 58 | 58 | $14,500 | $5,061 | 34.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 56 | 65 | $10,400 | $4,660 | 44.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 33 | 33 | $10,230 | $4,459 | 43.6% |
About Dr. Ryan Yoder, M.D
Dr. Ryan Yoder, M.D is a Neurology healthcare provider based in Battle Creek, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700994019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Yoder, M.D has received a total of $8,339 in payments from pharmaceutical and medical device companies, with $2,380 received in 2024. These payments were reported across 513 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($8,237).
As a Medicare-enrolled provider, Yoder has provided services to 1,710 Medicare beneficiaries, totaling 1,882 services with total Medicare billing of $139,185. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Battle Creek, MI
- Active Since 08/27/2006
- Last Updated 11/27/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1700994019
Products in Payments
- NURTEC ODT (Drug) $770.79
- ZEPOSIA (Drug) $612.39
- QULIPTA (Drug) $388.19
- UBRELVY (Drug) $354.15
- VYVGART (Drug) $299.90
- VALTOCO (Drug) $295.32
- AUSTEDO (Drug) $286.50
- NUPLAZID (Drug) $277.17
- TROKENDI XR (Drug) $250.68
- Briviact (Drug) $239.79
- Austedo XR (Drug) $224.45
- AJOVY (Biological) $219.70
- KESIMPTA (Drug) $191.99
- Aimovig (Biological) $155.59
- Leqembi (Drug) $139.60
- EPIDIOLEX (Drug) $135.57
- BOTOX (Biological) $130.43
- VYEPTI (Biological) $119.49
- Nourianz (Drug) $118.47
- XCOPRI (Drug) $117.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Battle Creek
Dr. Daniel Hood, M.d, M.D
Neurology — Payments: $5,742
Neurology $5,742
Dr. Jeffrey Jones, M.d, M.D
Neurology — Payments: $42.54
Neurology $42.54
Dr. Byron Campbell, M.d, M.D
Neurology — Payments: $42.54
Neurology $42.54
Dr. Beau Doubleday, D.c., D.a.c.n.b, D.C., D.A.C.N.B
Neurology
Neurology
Ashok Sachdev, Md, MD
Neurology
Neurology
Dominic Fetterly, Dc, DC
Neurology
Neurology